Adverum Biotechnologies, Inc.

NASDAQ:ADVM

4.74 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012
Revenue 3.607.500.251.6121.8491.4552.3190.5720.480.03
Cost of Revenue 5.6446.5284.6454.158002.09600000
Gross Profit -2.044-6.5282.855-4.1580.251.612-0.2471.4552.3190.5720.480.03
Gross Profit Ratio -0.56800.381011-0.13411111
Reseach & Development Expenses 77.67699.27789.18173.30940.41950.13339.83931.6725.46216.9762.1511.31
General & Administrative Expenses 49.91557.85864.44144.64128.37624.5620.85724.35522.1077.9981.7830.536
Selling & Marketing Expenses 000000000000
SG&A 49.91557.85864.44144.64128.37624.5620.85724.35522.1077.9981.7830.536
Other Expenses 02.6730.5821.5574.0594.2042.70.7620.37-1.002-0.096-0.006
Operating Expenses 127.591157.135153.622117.9568.79574.69360.69656.02547.56924.9743.4541.816
Operating Income -123.791-157.135-146.122-117.95-68.545-78.081-58.847-115.284-47.823-24.402-3.454-1.816
Operating Income Ratio -34.3860-19.4830-274.18-48.437-31.826-79.233-20.622-42.661-7.196-60.533
Total Other Income Expenses Net 5.5480.549-0.4811.5574.059-0.7962.7-62.126-2.103-1.002-1.8220.005
Income Before Tax -118.243-154.462-145.54-116.393-64.486-73.877-56.147-114.522-47.453-25.404-5.276-1.811
Income Before Tax Ratio -32.8450-19.4050-257.944-45.829-30.366-78.709-20.463-44.413-10.992-60.367
Income Tax Expense -1.0780.0744.4081.1141.401-1.250-0.7751.761-0.162-0.0230.002
Net Income -117.165-154.536-145.54-117.507-64.486-72.627-56.147-113.747-47.453-25.404-5.276-1.811
Net Income Ratio -32.5460-19.4050-257.944-45.054-30.366-78.177-20.463-44.413-10.992-60.367
EPS -11.62-15.57-14.85-13.8-10.06-1.18-1.29-3.14-1.86-1.12-0.25-0.087
EPS Diluted -11.62-15.57-14.85-13.8-10.06-1.18-1.29-3.14-1.84-1.12-0.25-0.087
EBITDA -112.599-147.934-140.895-112.235-62.913-72.127-54.051-52.967-46.741-25.224-3.524-1.821
EBITDA Ratio -31.2780-18.8640-267.888-41.148-30.6934.223-18.403-42.661-7.342-60.7